Rifaximin Prophylaxis for Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome in Cirrhotic Patients
Clinical trial NCT05621005 · COMPLETED
Trial details
- NCT number
- NCT05621005
- Sponsor
- Samar Atef Sebaweh Mohammed
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2022-07-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.